← back to search

Sanford J. Shattil

University of California San Diego · US
Area of research
Hematology · Immunology and Allergy
Research interest
Research interests include Cell Adhesion Molecules Research, Platelet Disorders and Treatments, Blood properties and coagulation, and Blood groups and transfusion.
h-index
96
citations
30,726
works
318
NIH funding
primary concept
email

Recent publications

Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
PubMed 2021cited by 153position: middledoi
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
Journal of Clinical Investigation 2019cited by 66position: middledoi
SHARPIN at the nexus of integrin, immune, and inflammatory signaling in human platelets
Proceedings of the National Academy of Sciences 2019cited by 42position: lastdoi
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018
Journal of the National Comprehensive Cancer Network 2018cited by 241position: middledoi
Integrin-based therapeutics: biological basis, clinical use and new drugs
Nature Reviews Drug Discovery 2016cited by 406position: lastdoi
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015
Journal of the National Comprehensive Cancer Network 2015cited by 216position: middledoi
The Classical Lancefield Antigen of Group A Streptococcus Is a Virulence Determinant with Implications for Vaccine Design
Cell Host & Microbe 2014cited by 158position: middledoi
Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
Developmental Cell 2014cited by 96position: middledoi
ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding
Blood 2014cited by 67position: lastdoi
The Mechanism of Kindlin-Mediated Activation of Integrin αIIbβ3
Current Biology 2013cited by 144position: middledoi
In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling
Oncogene 2012cited by 132position: middledoi
The Primacy of β1 Integrin Activation in the Metastatic Cascade
PLoS ONE 2012cited by 65position: lastdoi
Kindlins, Integrin Activation and the Regulation of Talin Recruitment to αIIbβ3
PLoS ONE 2012cited by 56position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Ana Kasirer‐Friede · University of California San Diego4 papers (2013–2019)Hisashi Kato · Kyoto Medical Center3 papers (2012–2012)Mark H. Ginsberg · Mahindra and Mahindra Limited (India)3 papers (2012–2014) · 2 papers (2012–2012)Zhongji Liao · University of California San Diego2 papers (2012–2019)Bryan N. Kahner · University of California San Diego2 papers (2012–2014) · 1 papers (2012–2012)Jason N. Cole · University of California San Diego1 papers (2014–2014)Joseph A. Merriman · Birmingham City Council1 papers (2014–2014)Beata Samelko · Rush University Medical Center1 papers (2019–2019)Shuangxin Liu · Rush University Medical Center1 papers (2019–2019)Changli Wei · China Geological Survey1 papers (2019–2019)Stefan Hägele · Rush University Medical Center1 papers (2019–2019)Victor Nizet · CNR de la Résistance aux Antibiotiques1 papers (2014–2014)John V. Mitsios · Siemens Healthcare (United States)1 papers (2012–2012) · 1 papers (2014–2014)Mark R. Davies · London School of Hygiene & Tropical Medicine1 papers (2014–2014) · 1 papers (2019–2019)Kirsten Kuipers · New York University1 papers (2014–2014)Jochen Reiser · Michigan Medicine1 papers (2019–2019)